Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fecal Microbiota Transplantation in Reducing Recurrence of Colorectal Adenomas After Endoscopic Resection: a Multicenter, Open-label, Randomized Controlled Study

NCT06205862 is registered in ClinicalTrials.gov with Shenzhen Hospital of Southern Medical University as lead sponsor.

NCT NCT06205862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06205862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fecal Microbiota Transplantation in Reducing Recurrence of Colorectal Adenomas After Endoscopic Resection: a Multicenter, Open-label, Randomized Controlled Study
Lead sponsor
Shenzhen Hospital of Southern Medical University
Phase
Phase 2
Overall status
Recruiting
Start date
April 9, 2024
Completion date
December 31, 2028
Enrollment
466 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, fecal microbiota transplantation, gastrointestinal microbiome